Clinical Trials Directory

Trials / Unknown

UnknownNCT05004103

Cosmetic Products and Facial Skin Microbiome

The Efficacy of Cosmetic Products and Its Effects on Facial Skin Microbiome

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The skin microbiome diversity in female healthy volunteers will be studied along with cosmetic products application in 1 month period. This study is also aimed to investigate the efficacy of cosmetic products on skin rejuvenation. .

Detailed description

The study is conducted in COVID-19 pandemic era, thus every person involved in this study must follow health protocol for COVID-19. The study procedure, consist of screening visit (D -7), 7-day wash out, baseline visit (D 0), first follow up ( D 14), and second follow up (D 28). 1. Screening visit: obtained Informed Consent, COVID-19 detection by swab RT-PCR, and inclusion and exclusion criteria, wash out product dispensing, and subject's diary dispensing. 2. Baseline visit: Investigator will check vital signs, facial skin value by Cutometer, Mexameter, Sebumeter, Corneometer, Colorimeter, Tewameter, dan pH meter, and kin taping by Corneofix tape. Investigational Products will dispensed in this visit for 2 weeks usage. 3. First follow up: Investigator will check vital signs and facial skin value. Investigational Products will dispensed in this visit for 2 weeks usage. 4. Second follow up: Investigator will check vital signs, facial skin value, and skin taping by Corneofix tape. All adverse events (AEs) occurred during study will be recorded in Case Report Form.

Conditions

Interventions

TypeNameDescription
OTHERCosmetic products applicationFemale healthy volunteers applied cosmetic products (cleanser and moisturizer) in the morning and afternoon for 1 month. Seven days wash out period will be conducted prior study starts. The evaluation will be conducted before, two weeks after treatment starts, and at the end of the study.

Timeline

Start date
2021-03-29
Primary completion
2021-05-31
Completion
2021-08-20
First posted
2021-08-13
Last updated
2021-08-13

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT05004103. Inclusion in this directory is not an endorsement.